| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 267.02B | 268.82B | 123.93B | 54.95B | 45.54B | 24.92B |
| Gross Profit | 41.30B | 37.45B | 19.17B | 7.88B | 7.46B | 4.71B |
| EBITDA | 14.80B | 15.69B | 9.00B | 3.61B | 3.49B | 1.32B |
| Net Income | -2.61B | -483.00M | 2.85B | 2.32B | 2.54B | 953.49M |
Balance Sheet | ||||||
| Total Assets | 161.17B | 159.47B | 137.58B | 51.20B | 42.01B | 30.69B |
| Cash, Cash Equivalents and Short-Term Investments | 15.53B | 12.97B | 16.23B | 9.51B | 7.34B | 5.28B |
| Total Debt | 120.56B | 120.47B | 102.12B | 30.12B | 22.96B | 16.25B |
| Total Liabilities | 136.25B | 134.00B | 114.45B | 33.91B | 27.36B | 19.07B |
| Stockholders Equity | 23.24B | 23.83B | 19.56B | 16.87B | 14.65B | 11.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -607.00M | 1.43B | -3.73B | -2.35B | -1.82B |
| Operating Cash Flow | 0.00 | 7.79B | 2.29B | -3.52B | -2.19B | -1.50B |
| Investing Cash Flow | 0.00 | -16.40B | -6.36B | -840.00M | -1.76B | -121.31M |
| Financing Cash Flow | 0.00 | 5.59B | 10.87B | 7.04B | 5.48B | 2.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥781.02B | 19.01 | 19.13% | 2.64% | 7.58% | 15.12% | |
66 Neutral | ¥129.12B | 8.08 | ― | 2.82% | 11.66% | -7.47% | |
63 Neutral | ¥60.58B | 10.40 | ― | 4.49% | 8.56% | -13.47% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥31.85B | 54.56 | ― | 5.36% | 23.82% | -151.12% | |
53 Neutral | ¥245.02B | 10.70 | ― | 1.24% | 21.79% | 9.89% | |
48 Neutral | ¥4.34B | -10.59 | ― | 1.08% | -2.36% | -1738.42% |